Atom Investors »

Oruka Therapeutics shares owned by Atom Investors

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 16k 95.17

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Viatris (VTRS)
Intel Corporation (INTC)
Hewlett Packard Enterprise (HPE)
Rhythm Pharmaceuticals (RYTM)
Esab Corporation (ESAB)
Ishares Msci Brazil Etf (EWZ)
Gxo Logistics Incorporated Common Stock (GXO)
Applied Materials (AMAT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
VSE Corporation (VSEC)
Apple (AAPL)
Immunome (IMNM)
John Bean Technologies Corporation (JBTM)

View all positions for Atom Investors

Top funds holding Oruka Therapeutics

FMR
BlackRock
VR Adviser
Fairmount Funds Management
Rtw Investments
Vanguard Capital Management
Paradigm Biocapital Advisors
Deep Track Capital
Bellevue Group
Franklin Resources
State Street Corporation
Remedium Capital Partners
RA Capital Management
Viking Global Investors
Geode Capital Management

View all funds holding Oruka Therapeutics